By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation and analyze site usage. View our Privacy Policy for more information.
Palantir (PLTR) stock just got a major nod of approval from Wall Street.
Veteran Rosenblatt Securities analyst John McPeake just raised his price target on the defense AI giant’s stock to $200 from $150, while reiterating a Buy rating in a recent note.